Authors: L. Bartošíková; J. Nečas; L. Fráňa 1; T. Bartošík 2 Authors‘ workplace: Univerzita Palackého, Lékařská fakulta, Ústav fyziologie, Olomouc ; Dům zdraví, Velké Meziříčí 1; Anesteziologicko-resuscitační klinika FN U sv. Anny v Brně 2 Published in: Čes. slov. Farm., 2007; 56, 276-279 Category: Original Articles
The study aimed to monitor the effectiveness and safety of the treatment with ciclesonide, administered once a day in a 160 μg dose, over a 3-month period, to a group of 100 patients diagnosed with mild persistent bronchial asthma with deterioration of problems after exercise. The results of the study prove significant positive effects of the preparation used. A significant improvement of FEV₁ and PEF values was observed, as well as a statistically significant remission of both day and nocturnal symptoms of the disease, a significantly lower consumption of shortacting β₂-sympathomimetics, and an improvement of all evaluated data relating to the quality of life of the asthmatic patients. No adverse effects were registered.
Key words: ciclesonide – inhaled corticosteroids – bronchial asthma
Don‘t have an account? Create new account
Enter the email address that you registered with. We will send you instructions on how to set a new password.
